ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/24/2026
Back to search
Official data from USPTO
IMMUNO-ONCOLOGY 360º
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNO-ONCOLOGY 360º
ST13
US500000088588735Class
35
Filing
88588735
Registration
6156574
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
06/24/2026
Trademark type
Word
Nice classes
35
Filing date
08/22/2019
Registration date
09/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2026
Last transaction
06/24/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/29/2015
First use in commerce
06/29/2015
Drawing code
4
Owner type
16
Owner location
DOVER, DE, US
Examiner
PRIZANT, JAMES
Current location
Historical data usage
Holders and representatives
Holders
QUESTEX, LLC
THE CONFERENCE FORUM LLC
THE CONFERENCE FORUM LLC
Representatives
Mark S. Kaufman Kaufman & Kahn, LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Organizing business networking events in the field of Life Sciences; Providing a live forum for companies to showcasedisplaydemonstrate and promote new and innovative ideasproducts and services in the convention/meeting management arena; Providing an in-person Business forum in the field of Life Sciences
Publications
History of USPTO decisions and trademark events.
21 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/14/2026
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/14/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/14/2026
E815
TEAS SECTION 8 & 15 RECEIVED
10/09/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/22/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2020
PUBO
PUBLISHED FOR OPPOSITION
07/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2020
ALIE
ASSIGNED TO LIE
04/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/23/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/04/2019
GNRT
NON-FINAL ACTION E-MAILED
12/04/2019
CNRT
NON-FINAL ACTION WRITTEN
12/04/2019
DOCK
ASSIGNED TO EXAMINER
11/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/06/2019
NWAP
NEW APPLICATION ENTERED
08/26/2019
Continuous trademark protection
Get notified about every new filing that threatens IMMUNO-ONCOLOGY 360º or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.